Abstract |
In human neuroblastoma, amplification of the MYCN gene predicts poor prognosis and resistance to therapy. In a shRNA screen of genes that are highly expressed in MYCN-amplified tumors, we have identified AURKA as a gene that is required for the growth of MYCN-amplified neuroblastoma cells but largely dispensable for cells lacking amplified MYCN. Aurora A has a critical function in regulating turnover of the N-Myc protein. Degradation of N-Myc requires sequential phosphorylation by cyclin B/Cdk1 and Gsk3. N-Myc is therefore degraded during mitosis in response to low levels of PI3-kinase activity. Aurora A interacts with both N-Myc and the SCF(Fbxw7) ubiquitin ligase that ubiquitinates N-Myc and counteracts degradation of N-Myc, thereby uncoupling N-Myc stability from growth factor-dependent signals.
|
Authors | Tobias Otto, Sebastian Horn, Markus Brockmann, Ursula Eilers, Lars Schüttrumpf, Nikita Popov, Anna Marie Kenney, Johannes H Schulte, Roderick Beijersbergen, Holger Christiansen, Bernd Berwanger, Martin Eilers |
Journal | Cancer cell
(Cancer Cell)
Vol. 15
Issue 1
Pg. 67-78
(Jan 06 2009)
ISSN: 1878-3686 [Electronic] United States |
PMID | 19111882
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cell Cycle Proteins
- F-Box Proteins
- F-Box-WD Repeat-Containing Protein 7
- FBXW7 protein, human
- Proto-Oncogene Proteins c-myc
- Ubiquitin-Protein Ligases
- AURKA protein, human
- Aurora Kinase A
- Aurora Kinases
- Protein Serine-Threonine Kinases
|
Topics |
- Aurora Kinase A
- Aurora Kinases
- Cell Cycle Proteins
(metabolism)
- Cell Line, Tumor
- Cell Proliferation
- F-Box Proteins
(metabolism)
- F-Box-WD Repeat-Containing Protein 7
- Humans
- Neuroblastoma
(genetics, metabolism, pathology)
- Protein Binding
- Protein Serine-Threonine Kinases
(genetics, metabolism)
- Proto-Oncogene Proteins c-myc
(genetics, metabolism)
- RNA Interference
- Ubiquitin-Protein Ligases
(metabolism)
|